Visual detection of HPV16 using a photoactivatable CRISPR–Cas12 system

Abstract

Human papillomavirus (HPV) screening is crucial for the diagnosis of cervical cancer. In this study, we have combined photoactivated CRISPR–Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm. It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.

Graphical abstract: Visual detection of HPV16 using a photoactivatable CRISPR–Cas12 system

Supplementary files

Article information

Article type
Communication
Submitted
20 Jan 2025
Accepted
18 Feb 2025
First published
18 Feb 2025

Chem. Commun., 2025, Advance Article

Visual detection of HPV16 using a photoactivatable CRISPR–Cas12 system

X. Gu, Z. Ma, L. Zhou, N. Li, S. Yu, F. Wang and R. An, Chem. Commun., 2025, Advance Article , DOI: 10.1039/D5CC00369E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements